Avocado/Soybean Unsaponifiables in Osteoarthritis Management

Avocado/soybean unsaponifiables (ASU) are a defined mixture of lipid extracts derived from avocado and soybean oils. These extracts are rich in plant sterols, tocopherols and phytosterols, which collectively exert anti-inflammatory and pro-anabolic effects on joint tissues. In osteoarthritis, ASU has been shown to inhibit key catabolic enzymes and inflammatory mediators—such as matrix metalloproteinases and prostaglandin E₂—while enhancing synthesis of cartilage matrix components including glycosaminoglycans and collagen. Clinically, ASU is employed as a slow-acting symptomatic therapy for hip and knee osteoarthritis, providing pain relief and functional improvement with an excellent safety profile. Beyond symptom control, preclinical evidence suggests potential disease-modifying properties through suppression of nitric oxide synthase activity and modulation of cytokine networks. ASU formulations are authorised in numerous countries as adjuncts to standard care, and ongoing research seeks to define optimal dosing, active constituents and combination strategies with other nutraceuticals or pharmaceutical agents.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Avocado/Soybean Unsaponifiables in Osteoarthritis Management publication trend

The graph below shows the total number of articles in avocado/soybean unsaponifiables in osteoarthritis management across all publications each year (not limited to Nature Index journals).

Technical terms

Chondroprotective: Describes an agent or mechanism that preserves cartilage integrity by reducing degradation and promoting matrix synthesis.

Matrix metalloproteinases (MMPs): A family of enzymes responsible for breakdown of extracellular matrix components, central to cartilage degradation in osteoarthritis.

Glycosaminoglycans: Long-chain polysaccharides within cartilage that confer resistance to compressive forces and maintain tissue hydration.

Synoviocytes: Cells lining the synovial membrane that produce synovial fluid and mediate inflammatory responses within joints.

References

1. Avocado–Soybean Unsaponifiables: A Panoply of Potentialities to Be Exploited. Biomolecules (2020).
2. Metabolic Effects of Avocado/Soy Unsaponifiables on Articular Chondrocytes. Evidence-based Complementary and Alternative Medicine (2007).
3. Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13. Arthritis Research & Therapy (2009).
4. Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis. PLOS ONE (2018).
5. Joint Dysfunctionality Alleviation along with Systemic Inflammation Reduction Following Arthrocen Treatment in Patients with Knee Osteoarthritis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Medicina (2022).